$NASDAQ:MYGN

Myriad Genetics Intrinsic Value – Myriad Genetics’ Weekly Ratings Receive Analysts’ Attention

🌥️Trending News Analysts have been paying close attention to the weekly ratings changes for Myriad Genetics ($NASDAQ:MYGN), Inc. The publicly [...]

By |December 30, 2023|Categories: Diagnostics & Research, Intrinsic Value|Tags: , , |0 Comments
Read More

Myriad Genetics Announces Retirement of CFO Riggsbee, Names Leffler as Successor

☀️Trending News Myriad Genetics ($NASDAQ:MYGN), a leading genetic testing and precision medicine company, has announced the retirement of CFO James [...]

By |December 22, 2023|Categories: Corporate Action, Diagnostics & Research|Tags: , , |0 Comments
Read More

Myriad Genetics Reaches Milestone, Celebrates One Million SneakPeek® Results Shared with Expectant Parents

☀️Trending News Myriad Genetics ($NASDAQ:MYGN), a biopharmaceutical company dedicated to transforming patient care, has reached a milestone, celebrating the one [...]

By |December 10, 2023|Categories: Diagnostics & Research|Tags: , , |0 Comments
Read More

MYRIAD GENETICS Reports Total Revenue Increase of 2.3% for Second Quarter of FY2023

☀️Earnings Overview For the second quarter of FY2023, MYRIAD GENETICS ($NASDAQ:MYGN) reported total revenue of USD 183.5 million, a 2.3% [...]

By |August 11, 2023|Categories: Diagnostics & Research, Earnings Report, Profitability|Tags: , , |0 Comments
Read More

Myriad Genetics Secures $90 Million Credit Facility to Advance Precision Medicine Initiatives

☀️Trending News Myriad Genetics ($NASDAQ:MYGN), a leader in genetic testing and precision medicine, today announced the establishment of a new [...]

By |July 8, 2023|Categories: Diagnostics & Research|Tags: , , |0 Comments
Read More

Investing Everyone Can Do.

Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.

Web App

Support Portal

Go to Top